Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neuroendocrine Cancer”

507 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 507 results

Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT04205227
What this trial is testing

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

Who this might be right for
CancerMelanomaOvary Cancer+2 more
ENB Therapeutics, Inc 137
Not applicableUnknownNCT03435770
What this trial is testing

Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms

Who this might be right for
Pancreatic CancerPancreatic NeoplasmsPancreatic Adenocarcinoma+2 more
Singapore General Hospital 10
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Testing effectiveness (Phase 2)Study completedNCT02132468
What this trial is testing

A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers

Who this might be right for
Neuroendocrine Tumors
Mateon Therapeutics 18
Not applicableUnknownNCT03517332
What this trial is testing

Circulating Tumor DNA Exposure in Peripheral Blood

Who this might be right for
Colorectal CancerPancreatic AdenocarcinomaGastric Cancer+8 more
Quantgene Inc. 10,000
Testing effectiveness (Phase 2)UnknownNCT03204019
What this trial is testing

Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Pancreatic Neuroendocrine Tumor
Chinese Academy of Medical Sciences 60
Testing effectiveness (Phase 2)Ended earlyNCT01392352
What this trial is testing

HYPAZ: Hypertension Induced by Pazopanib

Who this might be right for
Renal Cell CarcinomaSoft Tissue SarcomaGlioblastoma+8 more
Cambridge University Hospitals NHS Foundation Trust 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06158516
What this trial is testing

Surufatinib as Adjuvant Therapy for Pancreatic Neuroendocrine Tumors

Who this might be right for
Pancreatic Neuroendocrine Tumor
Changhai Hospital 100
Testing effectiveness (Phase 2)Study completedNCT01845675
What this trial is testing

Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Well-differentiated Pancreatic Neuroendocrine Tumor
Peking Union Medical College Hospital 14
Not applicableLooking for participantsNCT05403177
What this trial is testing

Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)

Who this might be right for
Breast CancerColorectal CancerPancreas Cancer+9 more
University Health Network, Toronto 500
Testing effectiveness (Phase 2)Study completedNCT00333502
What this trial is testing

Study of CRLX101 (NLG207) in the Treatment of Advanced Solid Tumors

Who this might be right for
CancerSolid Tumor
NewLink Genetics Corporation 62
Not applicableWithdrawnNCT06554730
What this trial is testing

MSD Belzutifan PAS

Who this might be right for
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
Early research (Phase 1)Looking for participantsNCT03454035
What this trial is testing

Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors

Who this might be right for
Tumor, SolidPancreatic CancerMelanoma
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Testing effectiveness (Phase 2)Active Not RecruitingNCT03600233
What this trial is testing

Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsPancreatic Neuroendocrine TumorGastro-enteropancreatic Neuroendocrine Tumor+2 more
TaiRx, Inc. 34
Early research (Phase 1)Study completedNCT02639026
What this trial is testing

Trial Of Hypofractionated Radiotherapy In Combination With MEDI4736 And Tremelimumab For Patients With Metastatic Melanoma And Lung, Breast And Pancreatic Cancers

Who this might be right for
MetastaticMelanomaNon Small Cell Lung Cancer (NSCLC)+2 more
Abramson Cancer Center at Penn Medicine 53
Testing effectiveness (Phase 2)UnknownNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 314
Testing effectiveness (Phase 2)Study completedNCT02893930
What this trial is testing

Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Neuroendocrine Tumor G1Pancreatic Neuroendocrine Tumor G2Refractory Pancreatic Neuroendocrine Carcinoma
National Cancer Institute (NCI) 13
Early research (Phase 1)Study completedNCT01935453
What this trial is testing

A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer

Who this might be right for
MelanomaLiver CancerPancreatic Cancer+1 more
OrienGene Biotechnology Ltd. 18
Load More Results